 "remdesivir, coronavirus, drugs, covid, pharma")
Remdesivir gets lukewarm endorsement: Gilead Sciences’s remdesivir is worth prescribing for patients with severe Covid-19, though evidence of its benefits remains inconclusive, according to a panel of international experts convened by the British Medical Journal. The effectiveness of most interventions with remdesivir is uncertain because most of the trials so far have been small and have limitations, the authors said in a review for the journal. Read more here
Let’s look at the global statistics:
Total Confirmed Cases: 17,039,160
Change Over Yesterday: 276,590
Total Confirmed Cases: 17,039,160
Change Over Yesterday: 276,590
Total Deaths: 673,568
Total Recovered: 10,151,894
Nations hit with most cases: US (4,495,015), Brazil (2,610,102), India
